Crizotinib failure in a TPM4- ALK-rearranged inflammatory myofibroblastic tumor with an emerging ALK kinase domain mutation

Kalliopi Tsakiri, Vassiliki Kotoula, Sotirios Lakis, Judith Müller, Florentia Fostira, Mattheos Bobos, Prodromos Hytiroglou, George Fountzilas

Research output: Contribution to journalArticlepeer-review

9 Scopus citations
Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalJCO Precision Oncology
Volume2017
Issue number1
DOIs
StatePublished - 2017
Externally publishedYes

Cite this